Project Lifeline-II: Feasibility of Implementing Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Allegheny County, Pennsylvania.

IF 3 4区医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Public Health Reports Pub Date : 2024-09-28 DOI:10.1177/00333549241277416

Renee M Cloutier, William N Dowd, Arnie Aldridge, Caitlin A Walsh, Brett A Messman, Jessica L Northcott, Abigail Talbert, Chronis Manolis, Vanessa Campbell, Janice L Pringle

{"title":"Project Lifeline-II: Feasibility of Implementing Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Allegheny County, Pennsylvania.","authors":"Renee M Cloutier, William N Dowd, Arnie Aldridge, Caitlin A Walsh, Brett A Messman, Jessica L Northcott, Abigail Talbert, Chronis Manolis, Vanessa Campbell, Janice L Pringle","doi":"10.1177/00333549241277416","DOIUrl":null,"url":null,"abstract":"Objectives: US community pharmacies are a unique and underused health service setting for identifying and potentially intervening with patients at risk of opioid overdose or opioid use disorder with evidence-based practices such as screening, brief intervention, and referral to treatment (SBIRT). The aim of our study was to assess the feasibility of implementing SBIRT in community pharmacies in an urban county in terms of engagement, reach, and equity across the cascade of pharmacy screening and care.Methods: Patients aged 18 years or older receiving a schedule II or III opioid prescription at 1 of 17 participating community pharmacies in Allegheny County, Pennsylvania, were invited to engage in SBIRT as part of Project Lifeline-II from June 2020 through January 2023. Participants completed a prescreen and/or a full screen. We calculated the percentage of patients who participated across the cascade of pharmacy screening and care, overall and by sex (male and female) and race (Black and White).Results: During the study period, 1952 unique adults (79.6%) were screened at least once (52.1% female; 58.0% White, 30.7% Black). Patients who identified as male (vs female) and Black (vs White) were more likely to have a positive prescreen (14.7% male vs 9.8% female; 16.4% Black vs 9.5% White), receive and complete a full screen (82.7% male vs 80.0% female; 83.6% Black vs 78.4% White), and score positively on the full screen (26.6% male vs 20.4% female; 26.8% Black vs 21.9% White).Conclusion: Although additional research is needed to characterize the full effect of Project Lifeline-II on patient outcomes, our findings help reinforce the benefits of multipronged public health initiatives that include community pharmacists to address the substance use disorder crisis in the United States.","PeriodicalId":20793,"journal":{"name":"Public Health Reports","volume":" ","pages":"333549241277416"},"PeriodicalIF":3.0000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556627/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00333549241277416","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: US community pharmacies are a unique and underused health service setting for identifying and potentially intervening with patients at risk of opioid overdose or opioid use disorder with evidence-based practices such as screening, brief intervention, and referral to treatment (SBIRT). The aim of our study was to assess the feasibility of implementing SBIRT in community pharmacies in an urban county in terms of engagement, reach, and equity across the cascade of pharmacy screening and care.

Methods: Patients aged 18 years or older receiving a schedule II or III opioid prescription at 1 of 17 participating community pharmacies in Allegheny County, Pennsylvania, were invited to engage in SBIRT as part of Project Lifeline-II from June 2020 through January 2023. Participants completed a prescreen and/or a full screen. We calculated the percentage of patients who participated across the cascade of pharmacy screening and care, overall and by sex (male and female) and race (Black and White).

Results: During the study period, 1952 unique adults (79.6%) were screened at least once (52.1% female; 58.0% White, 30.7% Black). Patients who identified as male (vs female) and Black (vs White) were more likely to have a positive prescreen (14.7% male vs 9.8% female; 16.4% Black vs 9.5% White), receive and complete a full screen (82.7% male vs 80.0% female; 83.6% Black vs 78.4% White), and score positively on the full screen (26.6% male vs 20.4% female; 26.8% Black vs 21.9% White).

Conclusion: Although additional research is needed to characterize the full effect of Project Lifeline-II on patient outcomes, our findings help reinforce the benefits of multipronged public health initiatives that include community pharmacists to address the substance use disorder crisis in the United States.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

项目 Lifeline-II：在宾夕法尼亚州阿勒格尼县实施筛查、简单干预和转介治疗 (SBIRT) 的可行性。

目标：美国社区药房是一种独特且未得到充分利用的医疗服务场所，可通过筛查、简单干预和转诊治疗（SBIRT）等循证实践来识别并干预有阿片类药物过量或阿片类药物使用障碍风险的患者。我们的研究旨在评估在一个城市社区药房实施 SBIRT 的可行性，包括参与度、覆盖面以及药房筛查和护理过程中的公平性：在宾夕法尼亚州阿勒格尼县的 17 家参与社区药房中的 1 家药房接受第二类或第三类阿片类处方的 18 岁或以上患者受邀参与 SBIRT，这是 2020 年 6 月至 2023 年 1 月期间生命线-II 项目的一部分。参与者完成了预筛查和/或全面筛查。我们按性别（男性和女性）和种族（黑人和白人）计算了在整个药房筛查和护理过程中参与的患者比例：在研究期间，1952 名成年人（79.6%）至少接受了一次筛查（52.1% 为女性；58.0% 为白人，30.7% 为黑人）。男性（vs 女性）和黑人（vs 白人）患者更有可能预检呈阳性（男性 14.7% vs 女性 9.8%；黑人 16.4% vs 白人 9.5%），更有可能接受并完成全面筛查（男性 82.7% vs 女性 80.0%；黑人 83.6% vs 白人 78.4%），更有可能在全面筛查中得分呈阳性（男性 26.6% vs 女性 20.4%；黑人 26.8% vs 白人 21.9%）：尽管还需要更多的研究来确定生命线-II 项目对患者治疗效果的全面影响，但我们的研究结果有助于加强包括社区药剂师在内的多管齐下的公共卫生举措的益处，以应对美国的药物使用障碍危机。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Public Health Reports 医学-公共卫生、环境卫生与职业卫生

CiteScore

5.00

自引率

6.10%

发文量

164

审稿时长

6-12 weeks

期刊介绍： Public Health Reports is the official journal of the Office of the U.S. Surgeon General and the U.S. Public Health Service and has been published since 1878. It is published bimonthly, plus supplement issues, through an official agreement with the Association of Schools and Programs of Public Health. The journal is peer-reviewed and publishes original research and commentaries in the areas of public health practice and methodology, original research, public health law, and public health schools and teaching. Issues contain regular commentaries by the U.S. Surgeon General and executives of the U.S. Department of Health and Human Services and the Office of the Assistant Secretary of Health. The journal focuses upon such topics as tobacco control, teenage violence, occupational disease and injury, immunization, drug policy, lead screening, health disparities, and many other key and emerging public health issues. In addition to the six regular issues, PHR produces supplemental issues approximately 2-5 times per year which focus on specific topics that are of particular interest to our readership. The journal''s contributors are on the front line of public health and they present their work in a readable and accessible format.